Trademark Overview
On Thursday, February 6, 2025, a trademark application was filed for KIFAMKA with the United States Patent and Trademark Office. The USPTO has given the KIFAMKA trademark a serial number of 99031102. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, February 6, 2025. This trademark is owned by Vertex Pharmaceuticals Incorporated. The KIFAMKA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated diseases